Mitschnitt des April-Webinars von Knowledge Rights 21. Thema: "Closed licences, closed doors: Open licensing, AI, and the future of research impact"

"Through two compelling case studies, you will see how open licensing can directly shaped scientific discovery: from Open Targets, a pioneering public-private drug target identification tool, to the COVID-19 pandemic response, where licensing frameworks shaped who could access and act on critical research."

https://www.youtube.com/watch?v=BprlLw6CRyI